The genetics of Alzheimer's disease

Handbook of Clinical Neurology

Volumn 89, Issue , 2008, Pages 223-232

  Bertram, Lars ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ANIMAL; CLASSIFICATION; GENETIC LINKAGE; GENETICS; HUMAN; REVIEW;

ALZHEIMER DISEASE; ANIMALS; GENETIC LINKAGE; HUMANS;

EID: 66049109678     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0072-9752(07)01221-3     Document Type: Review

References (61)

1. Adighibe O., Arepalli S., Duckworth J., et al. Genetic variability at the LXR gene (NR1H2) may contribute to the risk of Alzheimer's disease. Neurobiol Aging 27 (2005) 1431-1434
2. Arango D., Cruts M., Torres O., et al. Systematic genetic study of Alzheimer disease in Latin America: mutation frequencies of the amyloid beta precursor protein and presenilin genes in Colombia. Am J Med Genet 103 (2001) 138-143
3. Bales K.R., Verina T., Cummins D.J., et al. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 96 (1999) 15233-15238
4. Beffert U., Cohn J.S., Petit-Turcotte C., et al. Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent. Brain Res 843 (1999) 87-94
5. Bertram L., and Tanzi R. Genetics of Alzheimer's disease (2003), ISN Neuropath Press, Basel 40-46
6. Bertram L., and Tanzi R.E. Alzheimer's disease: One disorder, too many genes?. Hum Mol Genet 13 (2004) R135-R141 Spec No 1:
7. Bertram L., Menon R., Mullin K., et al. PEN2 is not a genetic risk factor for Alzheimer's disease in a large family sample. Neurology 62 (2004) 304-306
8. Bertram L., McQueen M.B., Mullin K., et al. Systematic Meta-Analyses of Alzheimer Disease Genetic Association Studies: The AlzGene Database. Nat Genet 39 (2007) 17-23
9. Blacker D., Haines J.L., Rodes L., et al. Apoe-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative. Neurology 48 (1997) 139-147
10. Blacker D., Bertram L., Saunders A.J., et al. Results of a high-resolution genome screen of 437 Alzheimer's Disease families. Hum Mol Genet 12 (2003) 23-32
11. Brouwers N., Sleegers K., Engelborghs S., et al. Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer's disease. Brain 129 (2006) 2984-2991
12. Burke W., Pinsky L.E., Press N.A., et al. Categorizing genetic tests to identify their ethical, legal, and social implications. Am J Med Genet 106 (2001) 233-240
13. Corder E.H., Saunders A.M., Risch N.J., et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 7 (1994) 180-184
14. Daw E.W., Payami H., Nemens E.J., et al. The number of trait loci in late-onset Alzheimer disease. Am J Hum Genet 66 (2000) 196-204
15. Farrer L.A., Cupples L.A., Haines J.L., et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278 (1997) 1349-1356
16. Finckh U. The future of genetic association studies in Alzheimer disease. J Neural Transm 110 (2003) 253-266
17. Gatz M., Reynolds C.A., Fratiglioni L., et al. Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry 63 (2006) 168-174
18. Goate A., Chartier-Harlin M.C., Mullan M., et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349 (1991) 704-706
19. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
20. Ioannidis J.P., Trikalinos T.A., Ntzani E.E., et al. Genetic associations in large versus small studies: an empirical assessment. Lancet 361 (2003) 567-571
21. Irizarry M.C., Deng A., Lleo A., et al. Apolipoprotein E modulates gamma-secretase cleavage of the amyloid precursor protein. J Neurochem 90 (2004) 1132-1143
22. Keavney B., McKenzie C., Parish S., et al. Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators. Lancet 355 (2000) 434-442
23. Levy-Lahad E., Wasco W., Poorkaj P., et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269 (1995) 973-977
24. Li G., Shofer J.B., Kukull W.A., et al. Serum cholesterol and risk of Alzheimer disease: A community-based cohort study. Neurology 65 (2005) 1045-1050
25. Lleo A., Blesa R., Queralt R., et al. Frequency of mutations in the presenilin and amyloid precursor protein genes in early-onset Alzheimer disease in Spain. Arch Neurol 59 (2002) 1759-1763
26. Lohmueller K.E., Pearce C.L., Pike M., et al. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33 (2003) 177-182
27. Mahley R.W., Weisgraber K.H., Huang Y., et al. Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci USA 103 (2006) 5644-5651
28. Meyer M.R., Tschanz J.T., Norton M.C., et al. APOE genotype predicts when-not whether-one is predisposed to develop Alzheimer disease. Nat Genet 19 (1998) 321-322
29. Mullan M., Houlden H., Windelspecht M., et al. A locus for familial early-onset Alzheimer's disease on the long arm of chromosome 14, proximal to the alpha 1-antichymotrypsin gene. Nat Genet 2 (1992) 340-342
30. Nacmias B., Latorraca S., Piersanti P., et al. Apoe genotype and familial Alzheimer's disease: a possible influence on age of onset in APP717 Val-->Ile mutated families. Neurosci Lett 183 (1995) 1-3
31. Ostojic J., Elfgren C., Passant U., et al. The tau R406W mutation causes progressive presenile dementia with bitemporal atrophy. Dement Geriatr Cogn Disord 17 (2004) 298-301
32. Ott A., Breteler M.M., van Harskamp F., et al. Incidence and risk of dementia. The Rotterdam Study. Am J Epidemiol 147 (1998) 574-580
33. Pericak-Vance M.A., Bebout J.L., Gaskell P.C., et al. Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am J Hum Genet 48 (1991) 1034-1050
34. Poduslo S.E., and Yin X. A new locus on chromosome 19 linked with late-onset Alzheimer's disease. Neuroreport 12 (2001) 3759-3761
35. Poirier J. Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism. Ann N Y Acad Sci 924 (2000) 81-90
36. Rademakers R., Dermaut B., Peters K., et al. Tau (MAPT) mutation Arg406Trp presenting clinically with Alzheimer disease does not share a common founder in Western Europe. Hum Mutat 22 (2003) 409-411
37. Rademakers R., Cruts M., Sleegers K., et al. Linkage and association studies identify a novel locus for Alzheimer disease at 7q36 in a dutch population-based sample. Am J Hum Genet 77 (2005) 643-652
38. Raux G., Guyant-Marechal L., Martin C., et al. Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update. J Med Genet 42 (2005) 793-795
39. Reitz C., Tang M.X., Luchsinger J., et al. Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol 61 (2004) 705-714
40. Risch N., and Merikangas K. The future of genetic studies of complex human diseases. Science 273 (1996) 1516-1517
41. Rocchi A., Pellegrini S., Siciliano G., et al. Causative and susceptibility genes for Alzheimer's disease: a review. Brain Res Bull 61 (2003) 1-24
42. Rogaev E.I., Sherrington R., Rogaeva E.A., et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376 (1995) 775-778
43. Rosso S.M., Donker Kaat L., Baks T., et al. Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain 126 (2003) 2016-2022
44. Rovelet-Lecrux A., Hannequin D., Raux G., et al. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 38 (2006) 24-26
45. Rumble B., Retallack R., Hilbich C., et al. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N Engl J Med 320 (1989) 1446-1452
46. Sala Frigerio C., Piscopo P., Calabrese E., et al. PEN-2 gene mutation in a familial Alzheimer's disease case. J Neurol 252 (2005) 1033-1036
47. Saunders A.M., Strittmatter W.J., Schmechel D., et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43 (1993) 1467-1472
48. Schellenberg G.D., Bird T.D., Wijsman E.M., et al. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 258 (1992) 668-671
49. Sherrington R., Rogaev E.I., Liang Y., et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375 (1995) 754-760
50. Sisodia S.S., and St George-Hyslop P.H. γ-Secretase, notch, Aβ and Alzheimer's disease: where do the presenilins fit in?. Nat Rev Neurosci 3 (2002) 281-290
51. Sleegers K., Brouwers N., Gijselinck I., et al. APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy. Brain 129 (2006) 2977-2983
52. St George-Hyslop P., Haines J., Rogaev E., et al. Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nat Genet 2 (1992) 330-334
53. Strittmatter W.J., Saunders A.M., Schmechel D., et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90 (1993) 1977-1981
54. Tanzi R.E. A genetic dichotomy model for the inheritance of Alzheimer's disease and common age-related disorders. J Clin Invest 104 (1999) 1175-1179
55. Tanzi R.E., and Ertram L. Twenty years of the Alzheimer's disease amyloid hypothesis: A genetic perspective. Cell 120 (2005) 545-555
56. Tanzi R.E., Gusella J.F., Watkins P.C., et al. Amyloid beta protein gene: cdna, mrna distribution, and genetic linkage near the Alzheimer locus. Science 235 (1987) 880-884
57. Theuns J., Brouwers N., Engelborghs S., et al. Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease. Am J Hum Genet 78 (2006) 936-946
58. Van Broeckhoven C., Backhovens H., Cruts M., et al. Mapping of a gene predisposing to early-onset Alzheimer's disease to chromosome 14q24.3. Nat Genet 2 (1992) 335-339
59. Wijsman E.M., Daw E.W., Yu C.E., et al. Evidence for a novel late-onset Alzheimer disease locus on chromosome 19p13.2. Am J Hum Genet 75 (2004) 398-409
60. Wisniewski K.E., Dalton A.J., McLachlan C., et al. Alzheimer's disease in Down's syndrome: Clinicopathologic studies. Neurology 35 (1985) 957-961
61. Wragg M., Hutton M., Talbot C., et al. Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Alzheimer's Disease Collaborative Group. Lancet 347 (1996) 509-512